Skip to main content

Seegene

Governance

Shareholders

Shareholder Rights

We respect the rights of shareholders and do our utmost to protect the basic rights granted to them pursuant to the Commercial Code of Korea and the Articles of Incorporation. Our shareholders are entitled to the following rights in accordance with the Commercial Code of Korea and the Articles of Incorporation:

Our shareholders are entitled to the following rights in accordance with the Commercial Law and the Articles of Incorporation.

Right to Pursue Common InterestsThis refers to the right to engage in, or participate in matters related to, the company’s business operations.
Right to Pursue Individual Profit This refers to the right that shareholders exercise to participate in a company’s profits or other benefits.
Specific ExamplesThe rights to pursue common interests and individual profit are illustrated in detail below. Exercising the right to pursue common interests may require equity ownership above the statutory threshold in accordance with the Commercial Code of Korea and other applicable laws and regulations.
Right to Pursue Common Interests
The right to call a general meeting of shareholders, the right to sue (e.g., for nullity of incorporation), voting rights, the right to seek an injunction against illegal acts committed by directors, the right to bring derivative lawsuits, inspection rights, the right to request the dismissal of directors/auditors, the right to request the inspection of a company’s operations and assets, the right to request the dissolution of the corporation, etc.
Right to Pursue Individual Profit
The right to receive dividends, the right to transfer securities ownership, preemptive rights, the right to residual assets, etc.

Shareholders

We respect the rights of shareholders and do our utmost to protect the basic rights granted to them pursuant to the Commercial Code of Korea and the Articles of Incorporation.

Occupational health and safety goals and performance
CategoryNumber of SharesPercentage of Total
TotalNaN%
All values are annual targets and performance for OHS.

Dividend

Dividend20242023202220212020
(the 25st fiscal year)(the 24th fiscal year)(the 23rd fiscal year)(the 22nd fiscal year)(the 21st fiscal year)
Total dividend (KRW million)36,94337,32040,45051,65838,987
Type of dividendCash dividendCash dividendCash dividendCash dividendCash dividend
(Consolidated) Dividend payout ratio(%)-5578.5%22.2%9.6%7.8%
Cash dividend yield (%)3.4%3.5%2.9%1.6%0.8%
Dividend per share (KRW)8008008001,0001,500

Annual General Meetings of Shareholders (Past 3 Years)

DateAgendaDecisionNote
FY 2024 Annual General Meeting (Mar 28, 2025)1. Approval of the financial statementsApproved-
2. Appointment of directors
- Appointment of the independent director Hyun-Chul Chung (reappointment)
Approved
3. Approval of the limit of compensation for directorsApproved
4. Approval of the limit of compensation for auditorsApproved
FY 2023 Annual General Meeting (Mar 22, 2024)1. Approval of the financial statementsApproved-
2. Partial amendment to the Articles of IncorporationApproved
3. Appointment of directors
- Appointment of the executive director Jong-Yoon Chun (reappointment)
- Appointment of the executive director Dae-Hoon Lee (new appointment)
Approved
4. Approval of the limit of compensation for directorsApproved
5. Appointment of the limit of compensation for auditorsApproved
FY 2022 Annual General Meeting (Mar 24, 2023)1. Approval of the financial statementsApproved-
2. Partial amendment to the Articles of IncorporationApproved
3. Appointment of directors
- Appointment of the executive director Jin-Su Choi (new appointment)
- Appointment of the independent director Chang-Se Lee (reappointment)
- Appointment of the non-executive director Kyong-Joon Chun (reappointment)
Approved
4. Appointment of auditors
- Appointment of the auditor Myung-Uk An (new appointment)
Approved
5. Approval of the limit of compensation for directorsApproved
6. Appointment of the limit of compensation for auditorsApproved

Board of Directors

The Board of Directors (BOD) is the highest decision-making body responsible for determining the company’s strategic direction and safeguarding the interests of both the company and its shareholders. The BOD plays a pivotal role in driving sustainable growth. Seegene aims to strengthen its foundation for sustainable management through transparent governance and sound board operations.

Composition and BSM (Board Skill Matrix)

As of December 2025

Jong-Yoon ChunDae-Hoon LeeJin-Su ChoiKyong-Joon ChunChang-Se LeeHyun-Chul Chung
CategoryExecutive Director, Chairperson of the BoardExecutive DirectorExecutive DirectorOther Non-executive DirectorIndependent DirectorIndependent Director
GenderMaleMaleMaleMaleMaleMale
RoleCEO / Overall Company ManagementHead of Diagnostics Business DivisionChair of Change Management CommitteeManagement AdvisorLegal Advisor / Chair of ESG CommitteeManagement Advisor
Career
  • CEO, Seegene Inc.
  • Former Professor, Ewha Womans University
  • Former Postdoctoral Fellow at Harvard University and University of California, Berkeley
  • Ph.D. in Life Sciences, Univ. of Tennessee
  • CEO, Seegene Inc.
  • Former EVP of R&D, Seegene Inc.
  • Ph.D. in Life Sciences, Seoul National University
  • President, Seegene Inc.
  • Former Director, Mando Corp.
  • Former CEO, Bontech Co.
  • LLB, Korea University
  • Other Non-Executive Director, Seegene Inc.
  • Former VP, Samsung Electronics
  • B.S. in Electronic Engineering, Hanyang University
  • Attorney, Dongin Law Firm
  • Former Director, Inspection Dept. Supreme Prosecutors' Office
  • LLB, Seoul National University
  • Vice President, Hanyang University
  • Former Director, Business Research Institute, Hanyang University
  • Former Chief of Planning, Hanyang University
  • Ph.D. in Business Administration, McGill University
Term2024-03-01 ~ Present2024-03-01 ~ Present2023-03-01 ~ Present2023-03-01 ~ Present2023-03-01 ~ Present2025-03-031) ~ Present
Expertise
Leadership●●●●--
Business Development and Strategy●●●●--
Management / Finance / Accounting●●●●-●
Legal / Regulatory--●-●-
ESG-●●-●●
Core Industry (Molecular diagnostics)●●----
Risk Management●●●-●●

1) Reappointment on March 28, 2025, terms of three years

Operational Status

Performance of BOD

MeetingDate of MeetingAgendaApprovalExecutive DirectorNon-Executive DirectorIndependent Director

Performance of ESG Committee

MeetingDateAgenda ItemsDecisionDirectors
Chang-Se LeeHyun-Chul ChungJung-Lyong KimJin-Su Choi
1st in 20252025. 05. 28.1. Implementation Results of 2024 ESG TasksReported--N/A-
2. Results of 2025 Materiality AssessmentReported--N/A-
3. 2025 ESG Improvement TasksApprovedForForN/AFor
4. Plan for 2025 Climate Change Scenario Analysis and DisclosureApprovedForForN/AFor
2nd in 20242024. 06. 07.1. Results of 2024 Materiality AssessmentReportedFor-N/A-
2. Publication of the 2023 Sustainability ReportReportedFor-N/A-
3. Implementation Results of 2024 ESG TasksReportedFor-N/A-
1st in 20242024. 03. 06.1. 2023 ESG Assessment ResultsReported--N/A-
2. Implementation Results of 2023 ESG TasksReported--N/A-
3. 2024 ESG Improvement TasksApprovedForForN/AFor
1st in 20232023. 03. 14.1. ESG Management Strategy FrameworkApprovedForForForN/A
2. Results of 2023 Materiality AssessmentApprovedForForForN/A
3. 2023 ESG Improvement TasksApprovedForForForN/A
4. 2023 ESG Assessment ResultsReported---N/A
5. Implementation Results of 2022 ESG TasksReported---N/A

Audit Body

Full-time Auditor

CategoryNameResponsibilityTenureCareer
Standing auditorMyung-Uk AnPerform audits on the company’s accounting and business operations2023-03-24 ~ Present
  • B.A. in Business Administration, Kyungpook National University
  • Former Full-time Auditor, OE Solution Co., Ltd.
  • Former Vice President, Innowave Co., Ltd.
  • Former Executive Director, Management Support Team, Samsung SNS Co., Ltd.
  • Former Team Leader / General Manager, Management Support Team, Samsung Electronics Co., Ltd.

Major Activities of the Auditor

MeetingDate of MeetingAgendaApprovalAuditor
Myung-Uk An
(attendance:
100%)
Jan. 20242024. 01. 15.1. Approval of Treasury Share DisposalApprovedFor
Mar. 20242024. 03. 06.1. Approval of the FY 2023 financial statementsApprovedFor
2. Approval of the Year-End Dividend for FY 2023ApprovedFor
3. Approval of the FY 2023 internal accounting control system operational reportApprovedFor
4. Convening of the FY 2023 Annual General Meeting of ShareholdersApprovedFor
5. Approval of the agenda of the FY 2023 Annual General Meeting of ShareholdersApprovedFor
6. Approval of the FY 2023 (draft) business reportApprovedFor
7. Adoption of an electronic voting system and Proxy SystemApprovedFor
8. Approval of the 2024 Occupational Safety and Health Management PlanApprovedFor
9. Setting of the dividend record date for 2024 Q1 dividend paymentApprovedFor
Mar. 20242024. 03. 22.1. Appointment of Co-CEOs with Individual Representation AuthorityApprovedFor
2. Appointment of the Board ChairApprovedFor
Apr. 20242024. 04. 19.1. Approval of the 2024 Capital Increase for the U.S. SubsidiaryApprovedFor
May 20242024. 05. 08.1. Approval of Q1 2024 Cash DividendApprovedFor
2. Setting of the dividend record date for 2024 Q2 dividend paymentApprovedFor
3. Appointment of Compliance OfficerApprovedFor
4. Amendment of Internal Accounting Control RegulationsApprovedFor
Jun. 20242024. 06. 10.1. Approval of the Acquisition of a Controlling Stake in Pentaworks Co., Ltd.ApprovedFor
2. Approval of Treasury Share DisposalApprovedFor
Jul. 20242024. 07. 12.1. Extension of Treasury Share Trust AgreementApprovedFor
Aug. 20242024. 08. 07.1. Approval of Q2 2024 Cash DividendApprovedFor
2. Setting of the dividend record date for 2024 Q3 dividend paymentApprovedFor
Sep. 20242024. 09. 10.1. Establishment of New Subsidiaries (NewCo) in Spain and IsraelApprovedFor
Nov. 20242024. 11. 06.1. Approval of Q3 2024 Cash DividendApprovedFor

External Auditor

Fiscal YearCategoryAuditorAudit OpinionBasis for Modified OpinionMaterial Uncertainty Related to Going ConcernEmphasis of MatterKey Audit Matters